Insulet Corp. (PODD) Misses Q1 EPS by 5c, Offers Guidance

Insulet Corp. (NASDAQ: PODD) reported Q1 EPS of ($0.11), $0.05 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $69.2 million versus the consensus estimate of $68.47 million.

Insulet Corp. sees FY2014 revenue of $295-315 million, versus the consensus of $306.49 million.

Insulet Corp. sees Q2 2014 revenue of $70-74 million, versus the consensus of $73.86 million.

For earnings history and earnings-related data on Insulet Corp. (PODD) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c